Author:
Látrová Klára,Havlová Noemi,Večeřová Renata,Pinkas Dominik,Bogdanová Kateřina,Kolář Milan,Fišer Radovan,Konopásek Ivo,Do Pham Duy Dinh,Rejman Dominik,Mikušová Gabriela
Abstract
AbstractLipophosphonoxins (LPPOs) are small modular synthetic antibacterial compounds that target the cytoplasmic membrane. First-generation LPPOs (LPPO I) exhibit an antimicrobial activity against Gram-positive bacteria; however they do not exhibit any activity against Gram-negatives. Second-generation LPPOs (LPPO II) also exhibit broadened activity against Gram-negatives. We investigated the reasons behind this different susceptibility of bacteria to the two generations of LPPOs using model membranes and the living model bacteria Bacillus subtilis and Escherichia coli. We show that both generations of LPPOs form oligomeric conductive pores and permeabilize the bacterial membrane of sensitive cells. LPPO activity is not affected by the value of the target membrane potential, and thus they are also active against persister cells. The insensitivity of Gram-negative bacteria to LPPO I is probably caused by the barrier function of the outer membrane with LPS. LPPO I is almost incapable of overcoming the outer membrane in living cells, and the presence of LPS in liposomes substantially reduces their activity. Further, the antimicrobial activity of LPPO is also influenced by the phospholipid composition of the target membrane. A higher proportion of phospholipids with neutral charge such as phosphatidylethanolamine or phosphatidylcholine reduces the LPPO permeabilizing potential.
Funder
Ministerstvo Školství, Mládeže a Tělovýchovy
Grantová Agentura, Univerzita Karlova
Ministerstvo Zdravotnictví Ceské Republiky
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Scott, W. R. & Tew, N. G. Mimics of host defense proteins; strategies for translation to therapeutic applications. Curr. Top. Med. Chem. 17, 576–589 (2017).
2. Lei, J. et al. The antimicrobial peptides and their potential clinical applications. Am. J. Transl. Res. 11, 3919–3931 (2019).
3. Chen, C. H. & Lu, T. K. Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics 9, 24 (2020).
4. Giuliani, A. et al. Antimicrobial peptides: Natural templates for synthetic membrane-active compounds. Cell. Mol. Life Sci. 65, 2450–2460 (2008).
5. Matsuzaki, K. Control of cell selectivity of antimicrobial peptides. Biochim. Biophys. Acta Biomembr. 1788, 1687–1692 (2009).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献